4//SEC Filing
PICKERING GRANT 4
Accession 0001649094-24-000115
CIK 0001649094other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:15 PM ET
Size
10.8 KB
Accession
0001649094-24-000115
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
PICKERING GRANT
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Sale
Common Stock
2024-12-02$94.06/sh−2,242$210,883→ 450,301 total - Sale
Common Stock
2024-12-02$92.06/sh−11,349$1,044,789→ 453,952 total - Sale
Common Stock
2024-12-02$93.06/sh−1,409$131,123→ 452,543 total
Holdings
- 137,398(indirect: By Trust)
Common Stock
- 137,398(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $91.68 to $92.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. The shares were sold at prices ranging from $92.72 to $93.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price reported is a weighted-average price. The shares were sold at prices ranging from $93.72 to $94.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- [F6]Shares are held directly by a trust for the benefit of the Reporting Person's son.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001258693
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:15 PM ET
- Size
- 10.8 KB